Nova Patents
AT478889T

Novel compounds as inhibitors of hepatitis C virus NS3 serine protease

Abstract

A compound, or enantiomers, stereoisomers, rotamers, tautomers or racemates of said compound, or a pharmaceutically acceptable salt, solvate or ester of said compound, said compound being selected from: ** ** Formula

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

34 members in 19 offices

This recordMember, by publication datePriority claim9 more offices are in the list below

Priority claims1

Priority claims
DocumentOfficeKindDate
54853504United States of AmericaP

Members34

Family members, oldest first
DocumentOfficeKind
TW200529823ATaiwan Province of ChinaA
AU2005222056A1AustraliaA1
CA2557249A1CanadaA1
WO2005087725A2World Intellectual Property Organization (WIPO)A2
WO2005087725A3World Intellectual Property Organization (WIPO)A3
US2005245458A1United States of AmericaA1
AR047903A1ArgentinaA1
NO20064357LNorwayL
KR20060124729ARepublic of KoreaA
IL177627A0IsraelA0
EP1737881A2European Patent Office (EPO)A2
US7186747B2United States of AmericaB2
HK1095837AHong Kong, ChinaA
HK1095837A1Hong Kong, ChinaA1
CN1972956AChinaA
US2007142300A1United States of AmericaA1
BRPI0508186ABrazilA
JP2007525511AJapanA
RU2006134002ARussian FederationA
EP1939213A1European Patent Office (EPO)A1
US7425576B2United States of AmericaB2
HK1118066AHong Kong, ChinaA
HK1118066A1Hong Kong, ChinaA1
ZA200607053BSouth AfricaB
EP1737881B1European Patent Office (EPO)B1
AT434621TAustriaT
ATE434621T1AustriaT1
DE602005015093D1GermanyD1
ES2327544T3SpainT3
EP1939213B1European Patent Office (EPO)B1
AT478889TThis recordAustriaT
ATE478889T1AustriaT1
DE602005023224D1GermanyD1
ES2349328T3SpainT3